Sulfonylureas: do we need to introspect safety again?
Authors:
- Devindra SehraDSDevindra Sehra
- Sudhish SehraSSSudhish Sehra
- Shiv Tej SehraSSShiv Tej Sehra
- 5 May 2011
- journal article
- review article
- Published by Taylor & Francis in Expert Opinion on Drug Safety
- Vol. 10 (6) , 851-861
Abstract
Introduction: Sulfonylureas (SUs) are the most commonly prescribed medications for type 2 diabetes mellitus worldwide. Differences among SUs for kinetic and adenosine triphosphate sensitive potassium (KATP) channels selectivity and consequential extrapancreatic effects, although recognized in literature, are not considered by treatment guidelines. Areas covered: The roles of SUs in various system-related adverse effects have not been well understood. Inconsistencies in the literature and lack of clinical trials assessing the long-term effects of monotherapy or combination therapy with SUs add to the concern. This review provides insights in issues concerning safety of SUs based on literature published between 1980 and 2011. A comprehensive search was carried out on PubMed, Embase and Cochrane databases using the search terms: sulfonylureas, sulfonylureas and KATP channels, sulfonylureas and cardiovascular (CV) effects and sulfonylureas side effects. Expert opinion: SUs have been linked to CV events, growt...Keywords
This publication has 78 references indexed in Scilit:
- Impact of Type of Preadmission Sulfonylureas on Mortality and Cardiovascular Outcomes in Diabetic Patients with Acute Myocardial InfarctionThe Journal of Clinical Endocrinology & Metabolism, 2010
- Glibenclamide-related excess in total and cardiovascular mortality risks: Data from large Ukrainian observational cohort studyDiabetes Research and Clinical Practice, 2009
- Sulfonylurea Receptor 1 Subunits of ATP-Sensitive Potassium Channels and Myocardial Ischemia/Reperfusion InjuryTrends in Cardiovascular Medicine, 2009
- Medical management of hyperglycaemia in type 2 diabetes mellitus: a consensus algorithm for the initiation and adjustment of therapyDiabetologia, 2008
- Is the Combination of Sulfonylureas and Metformin Associated With an Increased Risk of Cardiovascular Disease or All-Cause Mortality?Diabetes Care, 2008
- The Effect of Sulphonylureas on the Microvascular and Macrovascular Complications of DiabetesCardiovascular Drugs and Therapy, 2008
- Review: Sulphonylureas and cardiovascular risk: facts and controversiesBritish Journal of Diabetes, 2006
- Do sulfonylurea drugs increase the risk of cardiac events?Canadian Medical Association Journal, 2006
- ATP-sensitive K+ channels in the hypothalamus are essential for the maintenance of glucose homeostasisNature Neuroscience, 2001
- United Kingdom Prospective Diabetes Study 17: A 9-Year Update of a Randomized, Controlled Trial on the Effect of Improved Metabolic Control on Complications in Non-Insulin-dependent Diabetes MellitusAnnals of Internal Medicine, 1996